0001209191-21-039571.txt : 20210610 0001209191-21-039571.hdr.sgml : 20210610 20210610172457 ACCESSION NUMBER: 0001209191-21-039571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210608 FILED AS OF DATE: 20210610 DATE AS OF CHANGE: 20210610 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paul Robert CENTRAL INDEX KEY: 0001757964 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38792 FILM NUMBER: 211009050 MAIL ADDRESS: STREET 1: C/O ALECTOR, INC. STREET 2: 151 OYSTER POINT BLVD., #300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alector, Inc. CENTRAL INDEX KEY: 0001653087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 462702363 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 151 OYSTER POINT BLVD., SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 415-231-5660 MAIL ADDRESS: STREET 1: 151 OYSTER POINT BLVD., SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Alector LLC DATE OF NAME CHANGE: 20150915 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-08 0 0001653087 Alector, Inc. ALEC 0001757964 Paul Robert C/O ALECTOR, INC. 131 OYSTER POINT BLVD, SUITE 600 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Medical Officer Common Stock 2021-06-08 4 M 0 7292 8.16 A 281011 D Common Stock 2021-06-08 4 M 0 11883 10.14 A 292894 D Common Stock 2021-06-08 4 S 0 16175 19.0004 D 276719 D Common Stock 2021-06-08 4 S 0 2200 19.8877 D 274519 D Common Stock 2021-06-08 4 S 0 800 20.8263 D 273719 D Employee Stock Option (right to buy) 8.16 2021-06-08 4 M 0 7292 0.00 D 2028-07-02 Common Stock 7292 115083 D Employee Stock Option (right to buy) 10.14 2021-06-08 4 M 0 11883 0.00 D 2028-11-06 Common Stock 11883 42284 D The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.61 to $19.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $20.59, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.64 to $21.08, inclusive. One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter. One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter. /s/ David Oh, attorney-in-fact 2021-06-10